Review: HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals
Source: Lancet Infectious Diseases
Area: News
The Lancet Infectious Diseases has featured a review discussing the management of patients with visceral leishmaniasis, and who are co-infected with HIV. Specifically, the review discusses the following topics:
. Protease inhibitors in HIV therapy
. Protease inhibitors and visceral leishmaniasis
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | Infectious Diseases